Tilray Brands, Inc. splits its revenue into 3 lines in its filings. The largest line in Q1 of fiscal 2027, the quarter ended Aug 31, 2026 was Beverage Alcohol Business at $104.2 million, 41% of the total.
USD in millions. The percent under a figure is the change from the same quarter a year earlier.
| Line |
TTM
Aug 31, 2026
|
Q1 FY2027
Aug 31, 2026
|
Q4 FY2026
May 31, 2026
|
Q3 FY2026
Feb 28, 2026
|
Q2 FY2026
Nov 30, 2025
|
Q1 FY2026
Aug 31, 2025
|
Q4 FY2025
May 31, 2025
|
Q3 FY2025
Feb 28, 2025
|
Q2 FY2025
Nov 30, 2024
|
|---|---|---|---|---|---|---|---|---|---|
| Revenue |
963
|
257
|
282
|
207
|
218
|
210
|
225
|
186
|
211
|
| Beverage Alcohol Business |
311
+23.2%
share 32.3%
|
104
+78.1%
share 40.5%
|
109
+57.4%
share 38.6%
|
45
-23.2%
share 21.5%
|
54
-19.9%
share 24.6%
|
59
share 27.9%
|
69
share 30.8%
|
58
share 31.2%
|
67
share 31.7%
|
| Distribution Business |
338
+21.8%
share 35.0%
|
84
share 32.8%
|
85
+14.7%
share 30.2%
|
83
+34.9%
share 40.1%
|
85
+26.2%
share 39.2%
|
—
|
74
share 33.0%
|
61
share 33.1%
|
68
share 32.1%
|
| Cannabis |
340
+0.8%
share 35.3%
|
75
-14.3%
share 29.2%
|
91
+1.5%
share 32.1%
|
84
+14.9%
share 40.6%
|
90
+3.4%
share 41.5%
|
88
share 41.9%
|
89
share 39.7%
|
73
share 39.3%
|
87
share 41.3%
|
How these figures are calculated
Quarterly columns are single-quarter amounts. When a 10-Q reports only a year-to-date total, as cash flow statements do, the quarter is that total minus the previous quarter's year-to-date total. The fourth quarter is the annual report's full year minus the first nine months. A column marked YTD is a year-to-date total, shown when the earlier report needed for the single quarter is missing. USD in millions. Each group is a separate split of total revenue, so the groups are not added together. Share of revenue is that line divided by total revenue. The first column adds the latest year-to-date segment amount to the last fiscal year and subtracts the year-ago year-to-date amount. More on our methodology.
Company profile
- Industry
- Medicinal Chemicals & Botanical Products (SIC 2833)
- Listed as
- TLRY (Nasdaq)
- Fiscal year ends
- May 31
- Headquarters
- New York, NY
- SEC filer status
- Large accelerated filer
- SEC CIK
- 1731348
- Former names
- Tilray, Inc. (until Jan 10, 2022)
Other Medicinal Chemicals & Botanical Products companies
- Definium Therapeutics, Inc. DFTX
- Regencell Bioscience Holdings Ltd RGC
- Curaleaf Holdings, Inc. CURLF
- Trulieve Cannabis Corp. TRLV
- Cronos Group Inc. CRON
- TFA Therapeutics, Inc. RAJAF
- SNDL Inc. SNDL
- Aurora Cannabis Inc ACB
Source: SEC EDGAR filings. This is company-reported data, not investment advice.